eli lilly phase 3 trial retatrutide Lilly's triple agonist achieves 16.8% weight loss in Eli Lilly's Retatrutide Shows Groundbreaking
Description
This article is for informational purposes only and does not replace medical advice
Diabetes Care (2014) 37:19107
Matt asked me what was wrong
For those interested, switching from tirzepatide to retatrutide is an emerging topic in the weight loss peptide space
Use the main body of the fridge, not the door, because the door temperature fluctuates more with opening and closing
With regard to nicotine use disorder, a randomized trial evaluating dulaglutide for smoking cessation found that abstinence rates at 12 weeks did not differ significantly between the dulaglutide and placebo groups (Lengsfeld et al., 2023)
